Correlation Between Duopharma Biotech and Public Packages

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Duopharma Biotech and Public Packages at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Duopharma Biotech and Public Packages into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Duopharma Biotech Bhd and Public Packages Holdings, you can compare the effects of market volatilities on Duopharma Biotech and Public Packages and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Duopharma Biotech with a short position of Public Packages. Check out your portfolio center. Please also check ongoing floating volatility patterns of Duopharma Biotech and Public Packages.

Diversification Opportunities for Duopharma Biotech and Public Packages

-0.27
  Correlation Coefficient

Very good diversification

The 3 months correlation between Duopharma and Public is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Duopharma Biotech Bhd and Public Packages Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Public Packages Holdings and Duopharma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Duopharma Biotech Bhd are associated (or correlated) with Public Packages. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Public Packages Holdings has no effect on the direction of Duopharma Biotech i.e., Duopharma Biotech and Public Packages go up and down completely randomly.

Pair Corralation between Duopharma Biotech and Public Packages

Assuming the 90 days trading horizon Duopharma Biotech Bhd is expected to under-perform the Public Packages. But the stock apears to be less risky and, when comparing its historical volatility, Duopharma Biotech Bhd is 1.31 times less risky than Public Packages. The stock trades about -0.13 of its potential returns per unit of risk. The Public Packages Holdings is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  77.00  in Public Packages Holdings on September 1, 2024 and sell it today you would earn a total of  3.00  from holding Public Packages Holdings or generate 3.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Duopharma Biotech Bhd  vs.  Public Packages Holdings

 Performance 
       Timeline  
Duopharma Biotech Bhd 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Duopharma Biotech Bhd are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Duopharma Biotech is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Public Packages Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Public Packages Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Duopharma Biotech and Public Packages Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Duopharma Biotech and Public Packages

The main advantage of trading using opposite Duopharma Biotech and Public Packages positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Duopharma Biotech position performs unexpectedly, Public Packages can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Public Packages will offset losses from the drop in Public Packages' long position.
The idea behind Duopharma Biotech Bhd and Public Packages Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Transaction History
View history of all your transactions and understand their impact on performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities